Henry Schein, Inc.

NASDAQ:HSIC

Medical - Distribution

Healthcare
$85.69 -1.53%

-$1.24 today

Market cap
$9.47B
Beta
0.82
P/E (TTM)
23.3
EPS (TTM)
$3.44
52W Low $61.95High $89.29

Volume 2.08M

Average 1.39M

HSIC Accounts Receivables

Cash effect of the change in amounts owed by customers; growing receivables consume cash.

Henry Schein, Inc.NASDAQ: HSIC

Accounts Receivables · Q2 FY2026 · quarter ended Jun 2026

Accounts receivables grows, but more slowly than its trailing trend

Q2 FY2026 accounts receivables of $47M (cash outflow) rose 80.8% year over year, behind the +154.5% change in trailing-twelve-month accounts receivables. Sequentially, it fell 31.9% from the prior quarter. Over 3 fiscal years it compounded at +160.7% a year.

Context

  • Accounts receivables amounted to 0.9% of revenue in FY2025, down 1.5 pp from a year earlier.
  • Accounts receivables increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth recovers from +80.8% toward the trailing-twelve-month pace of +154.5%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
-$47M-31.9% QoQ
Last fiscal yearDec 2025
-$124M-139.4% YoY
LTMJun 2026
-$140M+154.5% YoY
Accounts Receivables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+80.8%——
1 year-139.4%——
3-year CAGR+160.7%——
5-year CAGR——
10-year CAGR——

Accounts Receivables history

USD · from the cash flow

Latest · FY2025
(124M) USD
Year-over-year change
-139.4%

Accounts Receivables vs competitors

How HSIC compares with its peers on the latest reported figures

  • HSIC's LTM Jun 2026 accounts receivables of $140M is the 4th largest of the 7 companies compared; the peer median is $332.45M.
  • Its year-over-year change of +154.5% is the 2nd highest of 7, against a peer median of -52.7%.
  • Accounts receivables amounts to 1.0% of revenue for HSIC, versus a peer median of 0.4%.
HSIC Competitors Peer median
Accounts Receivables for HSIC and competitors
Company Period LTM YoY 3-year CAGR% of revenue
MCKMcKesson CorporationLTM Jun 2026$2.28B -41.8%+22.7%0.6%
CORCencora, Inc.LTM Jun 2026$1.7B +136.2%+5.0%0.5%
CAHCardinal Health, Inc.LTM Sep 2026$603M -63.7%-24.6%0.2%
HSICHenry Schein, Inc.LTM Jun 2026$140M +154.5%+160.7%1.0%
NVSTEnvista Holdings CorpLTM Oct 2026$61.9M +387.4%-11.9%2.2%
ACHAccendra Health, Inc.LTM Mar 2026$2.95M -96.7%+380.8%0.1%
XRAYDENTSPLY SIRONA Inc.LTM Mar 2026$0 -100.0%—0.0%
Peer median (excluding HSIC) $332.45M-52.7%+5.0%0.4%

Competitors are the stored peer set for HSIC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income660.53M566M416M398M398M
Depreciation & Amortization209.53M212M222M268M311M
Deferred Income Tax(12.93M)(61M)0(56M)5M
Stock-Based Compensation78M54M39M39M0
Change in Working Capital(197.2M)(281M)(234M)140M(48M)
Accounts Receivables4.16M(7M)(327M)315M(124M)
Inventory(295.13M)(126M)231M(59M)(95M)
Accounts Payables84.71M(96M)0(163M)216M
Other Working Capital9.06M(52M)(138M)47M(45M)
Other Non-Cash Items(28.34M)112M57M59M46M
Operating Cash Flow709.58M602M500M848M712M
Capital Expenditures(79.02M)(96M)(187M)(187M)(139M)
Acquisitions (Net)(560.8M)(158M)(955M)(230M)(276M)
Purchases of Investments(7.32M)(11M)000
Sales of Investments7.32M11M22M4M0
Other Investing Activities(37.4M)(22M)(55M)(56M)(10M)
Investing Cash Flow(677.22M)(276M)(1.14B)(430M)(477M)
Debt Repayment165M259M900M189M551M
Common Stock Issued0000252M
Common Stock Repurchased(401M)(485M)(284M)(385M)(850M)
Dividends Paid00000
Other Financing Activities(88.96M)(57M)85M(314M)(64M)
Financing Cash Flow(332.96M)(315M)701M(510M)(111M)
Effect of Forex Changes(2.63M)(12M)(12M)43M(90M)
Net Change in Cash(303.22M)(1M)54M(49M)34M
Free Cash Flow630.57M506M313M661M573M

Henry Schein, Inc.

NASDAQ:HSIC

Intrinsic Alpha fair value

Locked

Current Price

$85.69

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.